| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹15,183 | +1.22% | |
| 6 months | ₹30,000 | ₹29,776 | -0.75% | |
| 1 year | ₹60,000 | ₹59,785 | -0.36% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Lupin Ltd. | Healthcare | Equity | 10.67% |
| Fortis Healthcare Ltd. | Healthcare | Equity | 7.87% |
| Laurus Labs Ltd. | Healthcare | Equity | 7.34% |
| Aurobindo Pharma Ltd. | Healthcare | Equity | 6.93% |
| Glenmark Pharmaceuticals Ltd. | Healthcare | Equity | 6.10% |
| Alkem Laboratories Ltd. | Healthcare | Equity | 5.89% |
| Biocon Ltd. | Healthcare | Equity | 4.90% |
| Mankind Pharma Ltd. | Healthcare | Equity | 4.31% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 4.23% |
| Aster DM Healthcare Ltd. | Healthcare | Equity | 3.22% |
| JB Chemicals & Pharmaceuticals Ltd. | Healthcare | Equity | 3.21% |
| Krishna Institute of Medical Sciences Ltd | Healthcare | Equity | 2.92% |
| Abbott India Ltd. | Healthcare | Equity | 2.57% |
| Gland Pharma Ltd. | Healthcare | Equity | 2.57% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 2.54% |
| Ajanta Pharma Ltd. | Healthcare | Equity | 2.25% |
| Narayana Hrudayalaya Ltd. | Healthcare | Equity | 2.11% |
| Neuland Laboratories Ltd. | Healthcare | Equity | 1.97% |
| Dr. Lal Pathlabs Ltd. | Healthcare | Equity | 1.94% |
| Wockhardt Ltd. | Healthcare | Equity | 1.85% |
| Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | Equity | 1.80% |
| Granules India Ltd. | Healthcare | Equity | 1.71% |
| Natco Pharma Ltd. | Healthcare | Equity | 1.66% |
| Piramal Pharma Ltd. | Healthcare | Equity | 1.61% |
| Global Health Ltd. | Healthcare | Equity | 1.55% |
| Onesource Specialty Pharma Ltd. | Healthcare | Equity | 1.55% |
| Syngene International Ltd. | Healthcare | Equity | 1.41% |
| Pfizer Ltd. | Healthcare | Equity | 1.36% |
| Cohance Lifesciences Ltd. | Healthcare | Equity | 0.93% |
| Poly Medicure Ltd. | Healthcare | Equity | 0.86% |
| Name | 3M | 6M | 1Y | All |
|---|---|---|---|---|
| Fund returns | -5.7% | -4.5% | +3.4% | +1.0% |
| Category average (Equity Sectoral) | -- | -- | -2.1% | -- |
| Rank (Equity Sectoral) | 10 | 12 | 7 | -- |